Commentary on a previous review article published by Kim SY et al

AbstractI read with great interest the literature review proposed by Kim SY and colleagues in the Journal issue dedicated to the role of HDL as potential disease biomarkers and therapeutic targets in systemic lupus erythematosus (SLE) (1) and felt that the part dedicated to anti ‐apoA‐I autoantibodies would certainly benefit from the following comments.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Tags: LETTER TO THE EDITOR Source Type: research